Artelo Biosciences launches public offering; shares down 10%

* Artelo Biosciences (NASDAQ:ARTL [https://seekingalpha.com/symbol/ARTL]) has commenced an underwritten public offering of common stock and/or pre-funded warrants.
* All securities in the offering will be sold by the company itself.
* The size, pricing, and terms of the offering are yet to be determined.
* Proceeds are expected to support the company’s clinical-stage programs targeting cancer, pain, and neurological conditions.
* ARTL shares down 9.9% post-market on Wednesday.
* Source: Press release [https://seekingalpha.com/pr/20220370-artelo-biosciences-announces-proposed-underwritten-public-offering]

MORE ON ATKINSRÉALIS GROUP INC.

* AtkinsRéalis Group Inc. 2025 Q2 - Results - Earnings Call Presentation [https://seekingalpha.com/article/4811173-atkinsrealis-group-inc-2025-q2-results-earnings-call-presentation]
* AtkinsRéalis Group Inc. Q2 2025 Earnings Call Transcript [https://seekingalpha.com/article/4811172-atkinsrealis-group-inc-sncaf-q2-2025-earnings-call-transcript]
* AtkinsRéalis to repurchase 7M shares from La Caisse [https://seekingalpha.com/news/4462460-atkinsralis-to-repurchase-7m-shares-from-la-caisse]
* Historical earnings data for AtkinsRéalis Group Inc. [https://seekingalpha.com/symbol/ATRL:CA/earnings]
* Dividend scorecard for AtkinsRéalis Group Inc. [https://seekingalpha.com/symbol/ATRL:CA/dividends/scorecard]